nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexrazoxane—TOP2A—Epirubicin—pancreatic cancer	0.425	0.653	CbGbCtD
Dexrazoxane—TOP2A—Doxorubicin—pancreatic cancer	0.226	0.347	CbGbCtD
Dexrazoxane—TOP2B—Topotecan—Irinotecan—pancreatic cancer	0.00621	0.598	CbGdCrCtD
Dexrazoxane—TOP2A—Topotecan—Irinotecan—pancreatic cancer	0.001	0.0965	CbGdCrCtD
Dexrazoxane—TOP2A—Paclitaxel—Docetaxel—pancreatic cancer	0.000704	0.0678	CbGdCrCtD
Dexrazoxane—TOP2A—Gefitinib—Erlotinib—pancreatic cancer	0.000676	0.065	CbGdCrCtD
Dexrazoxane—Diarrhoea—Tamoxifen—pancreatic cancer	0.000345	0.00102	CcSEcCtD
Dexrazoxane—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.000344	0.00102	CcSEcCtD
Dexrazoxane—Infection—Gemcitabine—pancreatic cancer	0.000344	0.00102	CcSEcCtD
Dexrazoxane—Abdominal pain—Sunitinib—pancreatic cancer	0.000341	0.00101	CcSEcCtD
Dexrazoxane—Body temperature increased—Sunitinib—pancreatic cancer	0.000341	0.00101	CcSEcCtD
Dexrazoxane—Diarrhoea—Erlotinib—pancreatic cancer	0.000341	0.00101	CcSEcCtD
Dexrazoxane—Oedema peripheral—Docetaxel—pancreatic cancer	0.000341	0.00101	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Docetaxel—pancreatic cancer	0.00034	0.001	CcSEcCtD
Dexrazoxane—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00034	0.001	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000339	0.001	CcSEcCtD
Dexrazoxane—Anorexia—Irinotecan—pancreatic cancer	0.000339	0.001	CcSEcCtD
Dexrazoxane—Hyponatraemia—Epirubicin—pancreatic cancer	0.000339	0.001	CcSEcCtD
Dexrazoxane—Infection—Fluorouracil—pancreatic cancer	0.000338	0.000999	CcSEcCtD
Dexrazoxane—Skin disorder—Gemcitabine—pancreatic cancer	0.000337	0.000993	CcSEcCtD
Dexrazoxane—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000334	0.000986	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000334	0.000984	CcSEcCtD
Dexrazoxane—Dizziness—Tamoxifen—pancreatic cancer	0.000333	0.000984	CcSEcCtD
Dexrazoxane—Anorexia—Gemcitabine—pancreatic cancer	0.00033	0.000974	CcSEcCtD
Dexrazoxane—Dizziness—Erlotinib—pancreatic cancer	0.00033	0.000973	CcSEcCtD
Dexrazoxane—Anorexia—Fluorouracil—pancreatic cancer	0.000325	0.000958	CcSEcCtD
Dexrazoxane—Insomnia—Irinotecan—pancreatic cancer	0.000322	0.000949	CcSEcCtD
Dexrazoxane—Cardiac disorder—Docetaxel—pancreatic cancer	0.000321	0.000948	CcSEcCtD
Dexrazoxane—Vomiting—Tamoxifen—pancreatic cancer	0.000321	0.000946	CcSEcCtD
Dexrazoxane—Vomiting—Erlotinib—pancreatic cancer	0.000317	0.000936	CcSEcCtD
Dexrazoxane—Dyspnoea—Irinotecan—pancreatic cancer	0.000317	0.000936	CcSEcCtD
Dexrazoxane—Somnolence—Irinotecan—pancreatic cancer	0.000316	0.000933	CcSEcCtD
Dexrazoxane—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000316	0.000933	CcSEcCtD
Dexrazoxane—Headache—Tamoxifen—pancreatic cancer	0.000316	0.000932	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000316	0.000931	CcSEcCtD
Dexrazoxane—Angiopathy—Docetaxel—pancreatic cancer	0.000314	0.000926	CcSEcCtD
Dexrazoxane—Hyponatraemia—Doxorubicin—pancreatic cancer	0.000313	0.000925	CcSEcCtD
Dexrazoxane—Insomnia—Gemcitabine—pancreatic cancer	0.000313	0.000925	CcSEcCtD
Dexrazoxane—Headache—Erlotinib—pancreatic cancer	0.000312	0.000922	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000312	0.00092	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00031	0.000916	CcSEcCtD
Dexrazoxane—Asthenia—Sunitinib—pancreatic cancer	0.00031	0.000914	CcSEcCtD
Dexrazoxane—Decreased appetite—Irinotecan—pancreatic cancer	0.000309	0.000912	CcSEcCtD
Dexrazoxane—Dyspnoea—Gemcitabine—pancreatic cancer	0.000309	0.000911	CcSEcCtD
Dexrazoxane—Insomnia—Fluorouracil—pancreatic cancer	0.000308	0.000909	CcSEcCtD
Dexrazoxane—Somnolence—Gemcitabine—pancreatic cancer	0.000308	0.000909	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000307	0.000906	CcSEcCtD
Dexrazoxane—Fatigue—Irinotecan—pancreatic cancer	0.000307	0.000905	CcSEcCtD
Dexrazoxane—Alopecia—Docetaxel—pancreatic cancer	0.000306	0.000902	CcSEcCtD
Dexrazoxane—Pruritus—Sunitinib—pancreatic cancer	0.000306	0.000901	CcSEcCtD
Dexrazoxane—Breast disorder—Epirubicin—pancreatic cancer	0.000305	0.0009	CcSEcCtD
Dexrazoxane—Constipation—Irinotecan—pancreatic cancer	0.000304	0.000897	CcSEcCtD
Dexrazoxane—Pain—Irinotecan—pancreatic cancer	0.000304	0.000897	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000304	0.000897	CcSEcCtD
Dexrazoxane—Dyspnoea—Fluorouracil—pancreatic cancer	0.000304	0.000896	CcSEcCtD
Dexrazoxane—Mental disorder—Docetaxel—pancreatic cancer	0.000303	0.000895	CcSEcCtD
Dexrazoxane—Somnolence—Fluorouracil—pancreatic cancer	0.000303	0.000894	CcSEcCtD
Dexrazoxane—Malnutrition—Docetaxel—pancreatic cancer	0.000301	0.000889	CcSEcCtD
Dexrazoxane—Erythema—Docetaxel—pancreatic cancer	0.000301	0.000889	CcSEcCtD
Dexrazoxane—Decreased appetite—Gemcitabine—pancreatic cancer	0.000301	0.000889	CcSEcCtD
Dexrazoxane—Nausea—Tamoxifen—pancreatic cancer	0.000299	0.000884	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000299	0.000883	CcSEcCtD
Dexrazoxane—Fatigue—Gemcitabine—pancreatic cancer	0.000299	0.000881	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000298	0.000878	CcSEcCtD
Dexrazoxane—Constipation—Gemcitabine—pancreatic cancer	0.000296	0.000874	CcSEcCtD
Dexrazoxane—Pain—Gemcitabine—pancreatic cancer	0.000296	0.000874	CcSEcCtD
Dexrazoxane—Nausea—Erlotinib—pancreatic cancer	0.000296	0.000874	CcSEcCtD
Dexrazoxane—Decreased appetite—Fluorouracil—pancreatic cancer	0.000296	0.000874	CcSEcCtD
Dexrazoxane—Diarrhoea—Sunitinib—pancreatic cancer	0.000295	0.000872	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000294	0.000868	CcSEcCtD
Dexrazoxane—Feeling abnormal—Irinotecan—pancreatic cancer	0.000293	0.000865	CcSEcCtD
Dexrazoxane—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000292	0.000863	CcSEcCtD
Dexrazoxane—Dysphagia—Epirubicin—pancreatic cancer	0.000292	0.00086	CcSEcCtD
Dexrazoxane—Pain—Fluorouracil—pancreatic cancer	0.000291	0.00086	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000291	0.000858	CcSEcCtD
Dexrazoxane—Dizziness—Sunitinib—pancreatic cancer	0.000286	0.000842	CcSEcCtD
Dexrazoxane—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000286	0.000842	CcSEcCtD
Dexrazoxane—Breast disorder—Doxorubicin—pancreatic cancer	0.000282	0.000832	CcSEcCtD
Dexrazoxane—Body temperature increased—Irinotecan—pancreatic cancer	0.000281	0.00083	CcSEcCtD
Dexrazoxane—Abdominal pain—Irinotecan—pancreatic cancer	0.000281	0.00083	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000281	0.00083	CcSEcCtD
Dexrazoxane—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000281	0.000828	CcSEcCtD
Dexrazoxane—Anaemia—Docetaxel—pancreatic cancer	0.000278	0.000822	CcSEcCtD
Dexrazoxane—Pancytopenia—Epirubicin—pancreatic cancer	0.000277	0.000817	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000275	0.000812	CcSEcCtD
Dexrazoxane—Vomiting—Sunitinib—pancreatic cancer	0.000275	0.00081	CcSEcCtD
Dexrazoxane—Body temperature increased—Gemcitabine—pancreatic cancer	0.000274	0.000808	CcSEcCtD
Dexrazoxane—Neutropenia—Epirubicin—pancreatic cancer	0.000273	0.000805	CcSEcCtD
Dexrazoxane—Urticaria—Fluorouracil—pancreatic cancer	0.000271	0.000798	CcSEcCtD
Dexrazoxane—Headache—Sunitinib—pancreatic cancer	0.000271	0.000798	CcSEcCtD
Dexrazoxane—Syncope—Docetaxel—pancreatic cancer	0.00027	0.000797	CcSEcCtD
Dexrazoxane—Dysphagia—Doxorubicin—pancreatic cancer	0.00027	0.000796	CcSEcCtD
Dexrazoxane—Leukopenia—Docetaxel—pancreatic cancer	0.00027	0.000796	CcSEcCtD
Dexrazoxane—Body temperature increased—Fluorouracil—pancreatic cancer	0.000269	0.000795	CcSEcCtD
Dexrazoxane—Loss of consciousness—Docetaxel—pancreatic cancer	0.000265	0.000781	CcSEcCtD
Dexrazoxane—Weight decreased—Epirubicin—pancreatic cancer	0.000264	0.000778	CcSEcCtD
Dexrazoxane—Cough—Docetaxel—pancreatic cancer	0.000263	0.000776	CcSEcCtD
Dexrazoxane—Pneumonia—Epirubicin—pancreatic cancer	0.000262	0.000772	CcSEcCtD
Dexrazoxane—Infestation NOS—Epirubicin—pancreatic cancer	0.00026	0.000767	CcSEcCtD
Dexrazoxane—Infestation—Epirubicin—pancreatic cancer	0.00026	0.000767	CcSEcCtD
Dexrazoxane—Myalgia—Docetaxel—pancreatic cancer	0.000256	0.000757	CcSEcCtD
Dexrazoxane—Nausea—Sunitinib—pancreatic cancer	0.000256	0.000757	CcSEcCtD
Dexrazoxane—Pancytopenia—Doxorubicin—pancreatic cancer	0.000256	0.000756	CcSEcCtD
Dexrazoxane—Asthenia—Irinotecan—pancreatic cancer	0.000255	0.000753	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000255	0.000752	CcSEcCtD
Dexrazoxane—TOP2A—Cytarabine—Gemcitabine—pancreatic cancer	0.000254	0.0245	CbGdCrCtD
Dexrazoxane—Stomatitis—Epirubicin—pancreatic cancer	0.000253	0.000748	CcSEcCtD
Dexrazoxane—Neutropenia—Doxorubicin—pancreatic cancer	0.000252	0.000745	CcSEcCtD
Dexrazoxane—Dry mouth—Docetaxel—pancreatic cancer	0.000251	0.00074	CcSEcCtD
Dexrazoxane—Asthenia—Gemcitabine—pancreatic cancer	0.000249	0.000733	CcSEcCtD
Dexrazoxane—Pruritus—Gemcitabine—pancreatic cancer	0.000245	0.000723	CcSEcCtD
Dexrazoxane—Infection—Docetaxel—pancreatic cancer	0.000244	0.000721	CcSEcCtD
Dexrazoxane—Weight decreased—Doxorubicin—pancreatic cancer	0.000244	0.00072	CcSEcCtD
Dexrazoxane—Diarrhoea—Irinotecan—pancreatic cancer	0.000243	0.000718	CcSEcCtD
Dexrazoxane—Agranulocytosis—Epirubicin—pancreatic cancer	0.000243	0.000716	CcSEcCtD
Dexrazoxane—Pneumonia—Doxorubicin—pancreatic cancer	0.000242	0.000714	CcSEcCtD
Dexrazoxane—Shock—Docetaxel—pancreatic cancer	0.000242	0.000714	CcSEcCtD
Dexrazoxane—Nervous system disorder—Docetaxel—pancreatic cancer	0.000241	0.000711	CcSEcCtD
Dexrazoxane—Pruritus—Fluorouracil—pancreatic cancer	0.000241	0.000711	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000241	0.00071	CcSEcCtD
Dexrazoxane—Infestation NOS—Doxorubicin—pancreatic cancer	0.000241	0.00071	CcSEcCtD
Dexrazoxane—Infestation—Doxorubicin—pancreatic cancer	0.000241	0.00071	CcSEcCtD
Dexrazoxane—Skin disorder—Docetaxel—pancreatic cancer	0.000239	0.000705	CcSEcCtD
Dexrazoxane—Diarrhoea—Gemcitabine—pancreatic cancer	0.000237	0.000699	CcSEcCtD
Dexrazoxane—TOP2A—Doxorubicin—Epirubicin—pancreatic cancer	0.000236	0.0227	CbGdCrCtD
Dexrazoxane—TOP2A—Idarubicin—Epirubicin—pancreatic cancer	0.000236	0.0227	CbGdCrCtD
Dexrazoxane—TOP2A—Daunorubicin—Epirubicin—pancreatic cancer	0.000236	0.0227	CbGdCrCtD
Dexrazoxane—Dizziness—Irinotecan—pancreatic cancer	0.000235	0.000694	CcSEcCtD
Dexrazoxane—Haemoglobin—Epirubicin—pancreatic cancer	0.000235	0.000692	CcSEcCtD
Dexrazoxane—Stomatitis—Doxorubicin—pancreatic cancer	0.000235	0.000692	CcSEcCtD
Dexrazoxane—Anorexia—Docetaxel—pancreatic cancer	0.000234	0.000692	CcSEcCtD
Dexrazoxane—Haemorrhage—Epirubicin—pancreatic cancer	0.000233	0.000689	CcSEcCtD
Dexrazoxane—Diarrhoea—Fluorouracil—pancreatic cancer	0.000233	0.000688	CcSEcCtD
Dexrazoxane—Oedema peripheral—Epirubicin—pancreatic cancer	0.00023	0.000678	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000229	0.000677	CcSEcCtD
Dexrazoxane—Vomiting—Irinotecan—pancreatic cancer	0.000226	0.000667	CcSEcCtD
Dexrazoxane—Dizziness—Fluorouracil—pancreatic cancer	0.000225	0.000665	CcSEcCtD
Dexrazoxane—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000225	0.000662	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000224	0.000661	CcSEcCtD
Dexrazoxane—Headache—Irinotecan—pancreatic cancer	0.000223	0.000657	CcSEcCtD
Dexrazoxane—Insomnia—Docetaxel—pancreatic cancer	0.000222	0.000656	CcSEcCtD
Dexrazoxane—Vomiting—Gemcitabine—pancreatic cancer	0.00022	0.00065	CcSEcCtD
Dexrazoxane—Dyspnoea—Docetaxel—pancreatic cancer	0.000219	0.000647	CcSEcCtD
Dexrazoxane—Somnolence—Docetaxel—pancreatic cancer	0.000219	0.000645	CcSEcCtD
Dexrazoxane—TOP2A—Epirubicin—Doxorubicin—pancreatic cancer	0.000218	0.021	CbGdCrCtD
Dexrazoxane—TOP2A—Idarubicin—Doxorubicin—pancreatic cancer	0.000218	0.021	CbGdCrCtD
Dexrazoxane—TOP2A—Daunorubicin—Doxorubicin—pancreatic cancer	0.000218	0.021	CbGdCrCtD
Dexrazoxane—Haemoglobin—Doxorubicin—pancreatic cancer	0.000217	0.000641	CcSEcCtD
Dexrazoxane—Headache—Gemcitabine—pancreatic cancer	0.000217	0.00064	CcSEcCtD
Dexrazoxane—Cardiac disorder—Epirubicin—pancreatic cancer	0.000217	0.000639	CcSEcCtD
Dexrazoxane—Vomiting—Fluorouracil—pancreatic cancer	0.000217	0.000639	CcSEcCtD
Dexrazoxane—Haemorrhage—Doxorubicin—pancreatic cancer	0.000216	0.000637	CcSEcCtD
Dexrazoxane—Decreased appetite—Docetaxel—pancreatic cancer	0.000214	0.000631	CcSEcCtD
Dexrazoxane—Headache—Fluorouracil—pancreatic cancer	0.000213	0.00063	CcSEcCtD
Dexrazoxane—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000213	0.000628	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000212	0.000626	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000212	0.000626	CcSEcCtD
Dexrazoxane—Fatigue—Docetaxel—pancreatic cancer	0.000212	0.000625	CcSEcCtD
Dexrazoxane—Angiopathy—Epirubicin—pancreatic cancer	0.000212	0.000625	CcSEcCtD
Dexrazoxane—Nausea—Irinotecan—pancreatic cancer	0.000211	0.000623	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Epirubicin—pancreatic cancer	0.00021	0.000621	CcSEcCtD
Dexrazoxane—Constipation—Docetaxel—pancreatic cancer	0.00021	0.00062	CcSEcCtD
Dexrazoxane—Pain—Docetaxel—pancreatic cancer	0.00021	0.00062	CcSEcCtD
Dexrazoxane—Alopecia—Epirubicin—pancreatic cancer	0.000206	0.000609	CcSEcCtD
Dexrazoxane—Nausea—Gemcitabine—pancreatic cancer	0.000206	0.000607	CcSEcCtD
Dexrazoxane—Mental disorder—Epirubicin—pancreatic cancer	0.000205	0.000603	CcSEcCtD
Dexrazoxane—Erythema—Epirubicin—pancreatic cancer	0.000203	0.0006	CcSEcCtD
Dexrazoxane—Malnutrition—Epirubicin—pancreatic cancer	0.000203	0.0006	CcSEcCtD
Dexrazoxane—Feeling abnormal—Docetaxel—pancreatic cancer	0.000203	0.000598	CcSEcCtD
Dexrazoxane—Nausea—Fluorouracil—pancreatic cancer	0.000202	0.000597	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000201	0.000593	CcSEcCtD
Dexrazoxane—Cardiac disorder—Doxorubicin—pancreatic cancer	0.0002	0.000591	CcSEcCtD
Dexrazoxane—Angiopathy—Doxorubicin—pancreatic cancer	0.000196	0.000578	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000195	0.000574	CcSEcCtD
Dexrazoxane—Abdominal pain—Docetaxel—pancreatic cancer	0.000194	0.000573	CcSEcCtD
Dexrazoxane—Body temperature increased—Docetaxel—pancreatic cancer	0.000194	0.000573	CcSEcCtD
Dexrazoxane—Alopecia—Doxorubicin—pancreatic cancer	0.000191	0.000563	CcSEcCtD
Dexrazoxane—Mental disorder—Doxorubicin—pancreatic cancer	0.000189	0.000558	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000189	0.000556	CcSEcCtD
Dexrazoxane—Erythema—Doxorubicin—pancreatic cancer	0.000188	0.000555	CcSEcCtD
Dexrazoxane—Malnutrition—Doxorubicin—pancreatic cancer	0.000188	0.000555	CcSEcCtD
Dexrazoxane—Anaemia—Epirubicin—pancreatic cancer	0.000188	0.000554	CcSEcCtD
Dexrazoxane—Malaise—Epirubicin—pancreatic cancer	0.000183	0.000541	CcSEcCtD
Dexrazoxane—TOP2A—Azacitidine—Gemcitabine—pancreatic cancer	0.000182	0.0175	CbGdCrCtD
Dexrazoxane—Syncope—Epirubicin—pancreatic cancer	0.000182	0.000538	CcSEcCtD
Dexrazoxane—Leukopenia—Epirubicin—pancreatic cancer	0.000182	0.000537	CcSEcCtD
Dexrazoxane—Loss of consciousness—Epirubicin—pancreatic cancer	0.000179	0.000527	CcSEcCtD
Dexrazoxane—Cough—Epirubicin—pancreatic cancer	0.000177	0.000523	CcSEcCtD
Dexrazoxane—Asthenia—Docetaxel—pancreatic cancer	0.000176	0.000521	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000174	0.000515	CcSEcCtD
Dexrazoxane—Pruritus—Docetaxel—pancreatic cancer	0.000174	0.000513	CcSEcCtD
Dexrazoxane—Anaemia—Doxorubicin—pancreatic cancer	0.000174	0.000513	CcSEcCtD
Dexrazoxane—Myalgia—Epirubicin—pancreatic cancer	0.000173	0.00051	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000172	0.000507	CcSEcCtD
Dexrazoxane—Discomfort—Epirubicin—pancreatic cancer	0.000171	0.000504	CcSEcCtD
Dexrazoxane—Malaise—Doxorubicin—pancreatic cancer	0.00017	0.0005	CcSEcCtD
Dexrazoxane—Dry mouth—Epirubicin—pancreatic cancer	0.000169	0.000499	CcSEcCtD
Dexrazoxane—Syncope—Doxorubicin—pancreatic cancer	0.000169	0.000497	CcSEcCtD
Dexrazoxane—Leukopenia—Doxorubicin—pancreatic cancer	0.000168	0.000497	CcSEcCtD
Dexrazoxane—Diarrhoea—Docetaxel—pancreatic cancer	0.000168	0.000496	CcSEcCtD
Dexrazoxane—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000165	0.000488	CcSEcCtD
Dexrazoxane—Infection—Epirubicin—pancreatic cancer	0.000165	0.000486	CcSEcCtD
Dexrazoxane—Cough—Doxorubicin—pancreatic cancer	0.000164	0.000484	CcSEcCtD
Dexrazoxane—Shock—Epirubicin—pancreatic cancer	0.000163	0.000481	CcSEcCtD
Dexrazoxane—Nervous system disorder—Epirubicin—pancreatic cancer	0.000163	0.00048	CcSEcCtD
Dexrazoxane—Dizziness—Docetaxel—pancreatic cancer	0.000163	0.00048	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000162	0.000479	CcSEcCtD
Dexrazoxane—Skin disorder—Epirubicin—pancreatic cancer	0.000161	0.000475	CcSEcCtD
Dexrazoxane—Myalgia—Doxorubicin—pancreatic cancer	0.00016	0.000472	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000159	0.000469	CcSEcCtD
Dexrazoxane—Discomfort—Doxorubicin—pancreatic cancer	0.000158	0.000467	CcSEcCtD
Dexrazoxane—Anorexia—Epirubicin—pancreatic cancer	0.000158	0.000466	CcSEcCtD
Dexrazoxane—Dry mouth—Doxorubicin—pancreatic cancer	0.000157	0.000462	CcSEcCtD
Dexrazoxane—Vomiting—Docetaxel—pancreatic cancer	0.000156	0.000461	CcSEcCtD
Dexrazoxane—Headache—Docetaxel—pancreatic cancer	0.000154	0.000454	CcSEcCtD
Dexrazoxane—Infection—Doxorubicin—pancreatic cancer	0.000152	0.00045	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000151	0.000446	CcSEcCtD
Dexrazoxane—Shock—Doxorubicin—pancreatic cancer	0.000151	0.000445	CcSEcCtD
Dexrazoxane—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00015	0.000444	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00015	0.000443	CcSEcCtD
Dexrazoxane—Insomnia—Epirubicin—pancreatic cancer	0.00015	0.000443	CcSEcCtD
Dexrazoxane—Skin disorder—Doxorubicin—pancreatic cancer	0.000149	0.00044	CcSEcCtD
Dexrazoxane—Dyspnoea—Epirubicin—pancreatic cancer	0.000148	0.000436	CcSEcCtD
Dexrazoxane—Somnolence—Epirubicin—pancreatic cancer	0.000147	0.000435	CcSEcCtD
Dexrazoxane—Anorexia—Doxorubicin—pancreatic cancer	0.000146	0.000432	CcSEcCtD
Dexrazoxane—Nausea—Docetaxel—pancreatic cancer	0.000146	0.000431	CcSEcCtD
Dexrazoxane—Decreased appetite—Epirubicin—pancreatic cancer	0.000144	0.000425	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000143	0.000422	CcSEcCtD
Dexrazoxane—Fatigue—Epirubicin—pancreatic cancer	0.000143	0.000422	CcSEcCtD
Dexrazoxane—Constipation—Epirubicin—pancreatic cancer	0.000142	0.000418	CcSEcCtD
Dexrazoxane—Pain—Epirubicin—pancreatic cancer	0.000142	0.000418	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.00014	0.000413	CcSEcCtD
Dexrazoxane—Insomnia—Doxorubicin—pancreatic cancer	0.000139	0.00041	CcSEcCtD
Dexrazoxane—Dyspnoea—Doxorubicin—pancreatic cancer	0.000137	0.000404	CcSEcCtD
Dexrazoxane—Feeling abnormal—Epirubicin—pancreatic cancer	0.000137	0.000403	CcSEcCtD
Dexrazoxane—Somnolence—Doxorubicin—pancreatic cancer	0.000136	0.000403	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000136	0.0004	CcSEcCtD
Dexrazoxane—Decreased appetite—Doxorubicin—pancreatic cancer	0.000133	0.000394	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000132	0.000391	CcSEcCtD
Dexrazoxane—Fatigue—Doxorubicin—pancreatic cancer	0.000132	0.00039	CcSEcCtD
Dexrazoxane—Urticaria—Epirubicin—pancreatic cancer	0.000132	0.000389	CcSEcCtD
Dexrazoxane—Pain—Doxorubicin—pancreatic cancer	0.000131	0.000387	CcSEcCtD
Dexrazoxane—Constipation—Doxorubicin—pancreatic cancer	0.000131	0.000387	CcSEcCtD
Dexrazoxane—Abdominal pain—Epirubicin—pancreatic cancer	0.000131	0.000387	CcSEcCtD
Dexrazoxane—Body temperature increased—Epirubicin—pancreatic cancer	0.000131	0.000387	CcSEcCtD
Dexrazoxane—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000126	0.000373	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000125	0.00037	CcSEcCtD
Dexrazoxane—Urticaria—Doxorubicin—pancreatic cancer	0.000122	0.00036	CcSEcCtD
Dexrazoxane—Body temperature increased—Doxorubicin—pancreatic cancer	0.000121	0.000358	CcSEcCtD
Dexrazoxane—Abdominal pain—Doxorubicin—pancreatic cancer	0.000121	0.000358	CcSEcCtD
Dexrazoxane—Asthenia—Epirubicin—pancreatic cancer	0.000119	0.000351	CcSEcCtD
Dexrazoxane—Pruritus—Epirubicin—pancreatic cancer	0.000117	0.000346	CcSEcCtD
Dexrazoxane—Diarrhoea—Epirubicin—pancreatic cancer	0.000113	0.000335	CcSEcCtD
Dexrazoxane—Asthenia—Doxorubicin—pancreatic cancer	0.00011	0.000325	CcSEcCtD
Dexrazoxane—Dizziness—Epirubicin—pancreatic cancer	0.00011	0.000324	CcSEcCtD
Dexrazoxane—Pruritus—Doxorubicin—pancreatic cancer	0.000109	0.00032	CcSEcCtD
Dexrazoxane—Vomiting—Epirubicin—pancreatic cancer	0.000105	0.000311	CcSEcCtD
Dexrazoxane—Diarrhoea—Doxorubicin—pancreatic cancer	0.000105	0.00031	CcSEcCtD
Dexrazoxane—Headache—Epirubicin—pancreatic cancer	0.000104	0.000307	CcSEcCtD
Dexrazoxane—Dizziness—Doxorubicin—pancreatic cancer	0.000101	0.000299	CcSEcCtD
Dexrazoxane—Nausea—Epirubicin—pancreatic cancer	9.85e-05	0.000291	CcSEcCtD
Dexrazoxane—Vomiting—Doxorubicin—pancreatic cancer	9.76e-05	0.000288	CcSEcCtD
Dexrazoxane—Headache—Doxorubicin—pancreatic cancer	9.61e-05	0.000284	CcSEcCtD
Dexrazoxane—Nausea—Doxorubicin—pancreatic cancer	9.11e-05	0.000269	CcSEcCtD
